ARTICLE | Clinical News
Onyx starts Phase III with CI-1042
June 6, 2000 7:00 AM UTC
ONXX and partner Warner-Lambert (WLA) started a 300-patient Phase III trial of CI-1042 (ONYX-015) to treat recurring head and neck cancer. The trial will compare intratumoral injection of CI-1042 with...